Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea

Abroad (travel likely)RecruitingPHASE3

Conditions

Primary Dysmenorrhea · Chronic Pelvic Pain

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Clinique axium / Centre resilience, Aix-en-Provence, France
Contact: Study coordinator (Christine LEVEQUE) · c.leveque.chir@gmail.com · 33 6 64 91 72 45
CHU Angers, Angers, France
Contact: Study coordinator (Léa DELBOS) · Lea.Delbos@chu-angers.fr · 33 2 41 35 64 92
CHU Brest, Brest, France
Contact: Study coordinator (Christie REBAHI) · christie.rebahi@chu-brest.fr · 33 2 98 22 35 32
CHU Lille, Lille, France
Contact: Study coordinator (Victoire DELPORTE) · Victoire.DELPORTE@chu-lille.fr · 33 3 20 44 66 41
Hôpital de la Croix-Rousse, Lyon, France
Contact: Study coordinator (Gil DUBERNARD) · gil.dubernard@chu-lyon.fr · 33 4 72 07 28 66
CHU Nantes, Nantes, France
Contact: Study coordinator (Claire CARDAILLAC) · claire.cardaillac@chu-nantes.fr · +33 2 53 48 23 50
Clinique Brétéché, Nantes, France
Contact: Study coordinator (Pascal CALMELET) · pcalmelet.pro@gmail.com · +33 2 51 86 88 13
CHU Rennes, Rennes, France
Contact: Study coordinator (Krystel NYANGOH-TIMOH) · Krystel.NYANGOH.TIMOH@chu-rennes.fr · 33 6 72 13 60 50

View source on ClinicalTrials.gov Contact study team (email)